Johnson & Johnson was ordered to pay $750 million in talc lawsuit. The New Jersey case includes four plaintiffs who claim that the company’s baby powder caused their cancer. J&J expects the penalty to be reduced to $185 million. (Reuters)

The World Health Organization has said it is too early to determine if coronavirus has peaked. However, China did record its first day of a drop in the number of new infections as the death toll reaches more than 560. (Reuters)

Bristol-Myers Squibb has reported a 33% jump in Q4 revenue. The company reported revenue of $7.95 billion in last quarter. Sales of its blockbuster immunotherapy cancer treatment Opdivo fell 2% to $1.76 billion in the quarter. (MarketWatch)

Retail and telecom giants are looking to healthcare. Companies like AT&T, Best Buy and Walmart are applying their strengths in wireless networks and foot traffic to healthcare. These retailers are also competing with big tech companies trying to break into healthcare. (STAT)

GSK is expected to cut jobs in its vaccines division. The company is restructuring the group and integrating it with the pharma side of the business. The European vaccine group may lose up to 935 jobs in the change. (Endpoints